new_0222_0315|TSHA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0315|TSHA|Long Name|1|1|Taysha Gene Therapies Inc Total Current Assets (Quarterly) (USD)|Taysha Gene Therapies Inc Cash and Short Term Investments (Quarterly) (USD)|Taysha Gene Therapies Inc Inventories (Quarterly) (USD)|Taysha Gene Therapies Inc Net PP&E (Quarterly) (USD)|Taysha Gene Therapies Inc Goodwill and Intangibles (Quarterly) (USD)|Taysha Gene Therapies Inc Total Liabilities (Quarterly) (USD)|Taysha Gene Therapies Inc Total Current Liabilities (Quarterly) (USD)|Taysha Gene Therapies Inc Total Long Term Liabilities (Quarterly) (USD)|Taysha Gene Therapies Inc Total Deposits (Quarterly) (USD)|Taysha Gene Therapies Inc Book Value (Quarterly) (USD)|Taysha Gene Therapies Inc Retained Earnings (Quarterly) (USD)|Taysha Gene Therapies Inc Treasury Stock (Quarterly) (USD)|Taysha Gene Therapies Inc EV to Revenues|Taysha Gene Therapies Inc EV to Earnings|Taysha Gene Therapies Inc EV to Free Cash Flow|Taysha Gene Therapies Inc EV to Assets (Quarterly)|Taysha Gene Therapies Inc PS Ratio|Taysha Gene Therapies Inc PE Ratio|Taysha Gene Therapies Inc Price to Book Value|Taysha Gene Therapies Inc PEG Ratio|Taysha Gene Therapies Inc Debt to Equity Ratio|Taysha Gene Therapies Inc Dividend Yield|Taysha Gene Therapies Inc Shareholder Yield (TTM)|Taysha Gene Therapies Inc Percent of Shares Outstanding Short|Taysha Gene Therapies Inc Total Receivables (Quarterly) (USD)|Taysha Gene Therapies Inc Total Payables (Quarterly) (USD)|Taysha Gene Therapies Inc Total Capital Stock (Quarterly) (USD)|Taysha Gene Therapies Inc Return on Invested Capital|Taysha Gene Therapies Inc Quality Ratio Score|Taysha Gene Therapies Inc Momentum Score|Taysha Gene Therapies Inc Beta (1Y)|Taysha Gene Therapies Inc Sustainable Growth Rate (TTM)|Taysha Gene Therapies Inc Institutional Investor Ownership Percentage|Taysha Gene Therapies Inc Average Diluted Shares Outstanding (Quarterly)|Taysha Gene Therapies Inc Total Employees (Annual)|Taysha Gene Therapies Inc EPS Diluted (Quarterly) (USD)|Taysha Gene Therapies Inc Shares Outstanding|Taysha Gene Therapies Inc Repurchase of Capital Stock (Quarterly) (USD)|Taysha Gene Therapies Inc Ordinary Shares Number (Quarterly)|Taysha Gene Therapies Inc Payout Ratio|Taysha Gene Therapies Inc Quick Ratio (Quarterly)|Taysha Gene Therapies Inc Normalized Diluted EPS (Quarterly) (USD)|Taysha Gene Therapies Inc Stock Buybacks (Quarterly) (USD)|Taysha Gene Therapies Inc Effective Tax Rate (TTM)|Taysha Gene Therapies Inc Return on Equity|Taysha Gene Therapies Inc Net Income (TTM) (USD)|Taysha Gene Therapies Inc Revenue (TTM) (USD)|Taysha Gene Therapies Inc Dividend Per Share (Quarterly) (USD)|Taysha Gene Therapies Inc Revenue (Quarterly) (USD)|Taysha Gene Therapies Inc Gross Profit (Quarterly) (USD)|Taysha Gene Therapies Inc SG&A Expense (Quarterly) (USD)|Taysha Gene Therapies Inc Pre-Tax Income (Quarterly) (USD)|Taysha Gene Therapies Inc Net Income (Quarterly) (USD)|Taysha Gene Therapies Inc Net Interest Income (Quarterly) (USD)|Taysha Gene Therapies Inc Price (USD)|Taysha Gene Therapies Inc Total Return Price (USD)|Taysha Gene Therapies Inc Enterprise Value (USD)|Taysha Gene Therapies Inc 30-Day Average Daily Volume|Taysha Gene Therapies Inc 1 Year Price Returns (Daily)
new_0222_0315|TSHA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0315|TSHA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0315|TSHA||5|5|91.4|91.4|0|91.4|0|91.4|91.4|91.4|0|91.4|91.4|0|0|0|1.44839857651|0|0|0|1.44637681159|0|0|1.44699140401|0|15.25|0|91.4|91.4|0|0|30.6666666667|30.75|0|30.5|91.2857142857|122|91.2857142857|28.9333333333|0|91.4|0|0|91.2857142857|91.25|0|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|91.2857142857|1.44699140401|1.44699140401|1.44699140401|1.45|1.44329896907
new_0222_0315|TSHA||6|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|281|0|0|0|345|0|0|349|0|32|0|5|5|0|0|3|4|0|14|7|1|7|15|0|5|0|0|7|4|0|0|4|0|0|0|0|7|7|7|7|349|349|349|320|97
new_0222_0315|TSHA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0315|TSHA|201912|201912|201912||||||||||||||||||||||||||||||||||15.1704||-0.0735||||||-0.0735|||||||||0.128|-1.115|-1.115|0|||||
new_0222_0315|TSHA|202003|202003|202003||||||||||||||||||||||||||||||||||15.1704||-0.358||||||-0.358|||||||||0.07|-5.431|-5.431|-0.027|||||
new_0222_0315|TSHA|202006|202006|202006|11.299|11.2||0.019||20.09|20.09|0||-8.772|-27.766|||||||||||||||1.311|0|||||||34.5214||-0.6147|||37.7614|||-0.6147|||||||||0.948|-21.22|-21.22|0|||||
new_0222_0315|TSHA|202008|202006|202006|||||||||||||||||||||||||||||||||||10||||||||||||||||||||||||
new_0222_0315|TSHA|202009|202009|202009|279.238|278.634||0.028||11.624|11.624|0||267.642|-42.808||||||||3.1604|||0||0.676||8.897|0|||||||11.7332||-1.28|37.7614||37.7614|||-1.28|-167.162|||-42.808|||||3.984|-15.042|-15.042|-0.001|22.4|22.4|567.2214||
new_0222_0315|TSHA|202010|202009|202009|||||||||||||||||||2.9347|||0||2.0047|||||||||||||||||||||||||||||||20.8|20.8|506.8031||
new_0222_0315|TSHA|202011|202009|202009|||||||||||||||||||3.1914|||0||2.199|||||||||99.5598||||37.7614||||||||||||||||||22.62|22.62|575.5289|91758.4333|
new_0222_0315|TSHA|202012|202012|202012|257.879|251.253||0.287||7.579|7.129|0.45||251.302|-61.126||||-24.4373||||3.988|||0||4.7988||1.994|0|||||||37.7614|38|-0.4851|37.7614||37.7614|||-0.4851|1.308|||-60.011|||||6.107|-18.318|-18.318|0.049|26.54|26.54|750.9346|165804.3667|
new_0222_0315|TSHA|202101|202012|202012|||||||||||||||-23.7737||||3.9068|||0||3.0422|||||||||||||||||||||||||||||||26|26|730.5434|168804.1333|
new_0222_0315|TSHA|202102|202012|202012|||||||||||||||-23.2699||||3.8452|||0||3.453|||||||||||||37.7614||||||||||||||||||25.59|25.59|715.0612|57104.6|
new_0222_0315|TSHA|202103|202103|202103|239.629|228.684||2.497||19.957|18.958|0.999||222.872|-93.15||||-8.8639||||3.4394|||0||3.7876||4.083|0|||||||36.9924||-0.87|37.7614||37.7614|||-0.87||||-86.604|||||8.236|-32.024|-32.024|0.066|20.3|20.3|537.8724|68440.3333|
new_0222_0315|TSHA|202104|202103|202103|||||||||||||||-12.3165||||4.3795|||0||3.5626|||||||||||||37.8172||||||||||||||||||25.81|25.81|747.3779|110296.0333|
new_0222_0315|TSHA|202105|202103|202103|||||||||||||||-10.2909||||3.828|||0||4.126|||||||||||||37.9175||||||||||||||||||22.5|22.5|624.4598|109262.4|
new_0222_0315|TSHA|202106|202106|202106|207.302|197.37||33.867||55.365|28.391|26.974||186.495|-134.076||||-7.125||||4.3642|||0||4.9369||6.355|0|||||||37.4792||-1.09|38.3912||38.3912|||-1.09||||-106.31|||||10.129|-40.926|-40.926|-0.154|21.2|21.2|616.5234|255547.3|
new_0222_0315|TSHA|202107|202106|202106|||||||||||||||-5.3903||||3.5593|||0||7.1977|||||||||||||||||||||||||||||||17.29|17.29|466.4138|238388.3333|
new_0222_0315|TSHA|202108|202106|202106|||||||||||||||-6.5394||||4.0924|||0||7.1172|||||||||||||38.3912||||||||||||||||||19.88|19.88|565.8471|82970.1|
new_0222_0315|TSHA|202109|202109|202109|197.17|188.785||40.553||100.648|43.214|57.434||140.394|-185.263||||-4.7997||||5.1027|||0||7.351||22.051|0||||1.4464|||38.004||-1.35|38.4739||38.4739|||-1.35|0|||-142.455|||||11.153|-51.187|-51.187|-0.506|18.62|18.62|555.411|92407.1333|-16.875
new_0222_0315|TSHA|202110|202109|202109|||||||||||||||-3.8089||||4.286|||0||6.2303||||||2|0.9456||||||||||||||||||||||||15.64|15.64|440.7588|106348.6667|-21.4859
new_0222_0315|TSHA|202111|202109|202109|||||||||||||||-2.9245||||3.5571|||0||6.7215||||||2|1.0474||||||38.4739||||||||||||||||||12.98|12.98|338.4182|205459.7667|-42.6172
new_0222_0315|TSHA|202112|202112|202112|||||||||||||||-2.4823||||3.1926|||0||7.8299||||||2|0.5718||91.4728||||||||||||||||||||||11.65|11.65|287.2479|195575.1|-56.104
new_0222_0315|TSHA|202201|202112|202112|||||||||||||||-1.2521||||2.1786|||0||8.611||||||2|1.6637||89.1145||||||||||||||||||||||7.95|7.95|144.8945|189163.4333|-69.4231
new_0222_0315|TSHA|202202|202112|202112|||||||||||||||-1.0593||||2.0197|||0|||||||||||||||||||||||||||||||||7.37|7.37|122.5796|219007.8667|-75.7725